首页>>国际

秦刚大使:美方在台湾问题上应遵守“契约精神”

2022-08-10 13:35:17 | 来源:普洱市新闻网
小字号

2022年8月9日,秦刚年夜使在出席福布斯第四届美中贸易论坛时,指出美众议长佩洛西执意拜候台湾严重违反了美方在台湾问题上的许诺,有背契约精力。秦年夜使暗示,美众议长佩洛西访台严重违背一个中国原则和中美三个结合公报划定,严重冲击中美关系政治根本,严重加害中国主权和国土完全,严重粉碎台海和安稳定。秦年夜使强调,美国人重视契约精力。在台湾问题上,中国当局的立场和中国人平易近的诉求很简单、很明白,即本身的河山不克不及被朋分,国度必需实现同一。美国所签订的国际文书,包罗1943年《开罗宣言》和1945年《波茨坦通知布告》必需要遵照,美国所做的双边许诺,包罗中美三个结合公报必需要履行。(本文来自彭湃新闻,更多原创资讯请下载“彭湃新闻”APP)

(责编:adkin)

分享让更多人看到

宜昌万寿桥多少钱一次
首页>>国际

2022全球发展倡议媒体对话会在西安举行

2022-08-10 13:17:18 | 来源:芦州新闻网
小字号

  中新网西安8月10日电 (杨英琦)9日,2022全球成长倡议媒体对话会在陕西西安进行。预会佳宾认为,成长是重年夜的世界性问题,也是全球治理亟待破解的困难,实现全球成长倡议火急需要媒体增强合作,促进交换、扩年夜共鸣,助力“一带一路”扶植,讲好全球成长命运配合体故事。   会议讲话环节,人平易近日报社编委、海外版总编纂陈贽提出,全球媒体应当增强内容合作,不竭深化交换,配合呼吁构建加倍公道公道的全球治理系统,营建有益成长的国际舆论情况。他认为,新闻媒体应聚焦减贫脱困、天气治理、数字经济等范畴,讲述一些“小而美”、接地气、聚人心的配合成长故事,促进国际社会对构建全球成长配合体的共识共情。   中国新闻社副总编纂兼中国新闻网总裁俞岚暗示,习近平主席提出的全球成长倡议包含着以人平易近为中间的成长理念。实现这一倡议火急需要增强对话交换,凝集最年夜共鸣、解除杂音干扰,媒体在此中饰演很是主要的脚色。作为中国内地两家通信社之一,中新社将进一步增强全球减贫、经贸合作、数据平权、应对天气转变等全球成长议题和涉侨新闻的报导传布工作力度,配合讲好全球成长命运配合体的故事。   马来西亚星报媒体团体首席履行官饶伟孝称,跟着更多成长机遇和新兴市场的呈现,媒体肩负着不带成见地报导全球成长的责任,应引领好社会转型期的信息传布。他认为,开放性对话和深切沟通交换是增进跨范畴、跨行业合作的要害。   埃塞俄比亚通信社副总裁特费拉·贝克勒·达巴认为,全球成长倡议的提出恰逢当时,旨在让列国通力合作,指导全球成长迈向平安、调和和包涵性增加的新阶段。   谈及助力全球成长的媒体责任,巴基斯坦《逐日邮报》社长兼总编纂马克东·巴伯暗示,在全球成长、世界和平、人性主义等方面,媒体都饰演侧重要脚色。他谈到,业内应延续思虑,媒体若何增进列国间的和平与协调,使列国更慎密地联系在一路。   埃及《共和国报》副总编纂穆斯塔法·埃尔布洛克提议,延续阐扬“一带一路”新闻合作同盟感化,增进“一带一路”沿线国度配合摸索新闻报导体例,增进列国专家间的紧密亲密合作,深化外界对“一带一路”倡议的认知。   当日,由人平易近日报社与陕西省委、省当局配合举行的2022“一带一路”媒体合作论坛在西安进行,论坛以“聚焦全球成长 深化互联互通”为主题,设置2022“一带一路”区域合作论坛和2022全球成长倡议媒体对话会两个分论坛。来自40多个国度和国际组织的120多位中外媒体代表以现场或视频、书面讲话体例参会。(完) 【编纂:刘湃】

(责编:adkin)

分享让更多人看到

Asia Cell & Gene Therapy Innovation Summit 2022
  • #CGT Asia 2022
  • August 9th-10th
  • Shanghai China

Asia Cell & Gene Therapy Innovation Summit 2022

0 +

Keynote
Speeches

0 +

Professional
Attendees

0 +

Featured
Booths

0 +

Global Cell&Gene
Therapy Enterprises

0 +

Media
Reports

Key words of the conference

Cell Therapy, Gene Therapy, Innovative Therapy, Next Generation Oncolytic Virus, End to End Development, CDMO, CRO, Regulation, IND Application, GLP, Clinical Trail Design, Continuous Production Process, GMP, Immunomodulation, Viral Vectors, High-Throughput Screening, Transfection, Combination Therapy, IVD, Digital PCR, CRISPR/CAS9 Gene Editing, Humanized Animal models, mRNA Tumor Vaccines, Nanoantibody, BsAbs, Customization Manufacturing, Tumor Microenvironment, Stem Cell Therapy, Recombinant Protein, Targets

Event Highlights

Cell Therapy Industrialization and Commercialization Module Strategy

TCR-T Therapy Market Prospects and Development Trends

Targets Selection and Direction of TCR-T Therapeutic Products

Development Key Points of Universal CAR-NK Cell Therapy Products

iPSC Personalized Diagnosis and Treatment and Application

Research and Development of mRNA Drug and Delivery Vector Technology

Viral Vector Process and Optimization Plan

Difficulty in the Development of Gene Therapy Drugs for Rare Diseases

Current Status of Circular RNA R&D

Who Should Attend

Biopharmaceutical CompaniesPre-Clinical R&DClinical R & DVaccine/Antibody CompaniesCell Therapy CompaniesGene Therapy CompaniesScientific Research InstitutesBiotechnology CompaniesLaboratory Equipment SuppliersDrug TestingAnalytical ServicesProduction Solution Providers (Upstream, Downstream) Life Science and Analytical EquipmentDiagnostic and Testing EquipmentExternal AuthorizationProtein Drugs CompaniesContract Service Providers (CRO, CMO, CDMO) Import and Export EnterprisesHVAC Facilities and Cleanroom Equipment SuppliersGovernment Representatives/Trading InstitutionsPreparation MachineryPharmaceutical EngineeringLaw and Regulation FirmsDrug Delivery System ManufacturersThird Party Logistics ProvidersAutomation/RobotCold Chain Packaging CompaniesPackaging MachineryIndustrial ParksLaboratory ServicesLaboratory/Biochemical/Analytical InstrumentsFine Chemical ManufacturersEnvironmental ProtectionIntermediate ManufacturersRegulatory ServicesSupply ChainNew Drug R & D CompaniesConsultant Companies


Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show
Exhibition & Show


Speakers

Dr. Xingwang XIE
Dr. Xingwang XIE

CEO

Corregene

Dr. Guojie YE
Dr. Guojie YE

CSO

EXEGENESIS BIO

Dr. Jinghui DOU
Dr. Jinghui DOU

CSO

TriApex Laboratories Co. LTD

Dr. Wenqiang YU
Dr. Wenqiang YU

Senior PI

Institutes of Biomedical Sciences Fudan University

Yan CHANG
Yan CHANG

President

INNOSTAR - National Shanghai Center for New Drug Safety Evaluation and Research

Dr. Xinpo JIANG
Dr. Xinpo JIANG

Associate Vice President, R&D, Catalog Product

GenScript

Mr. Hongdong YU
Mr. Hongdong YU

Director of Biological Culture Scenario

Haier Biomedical

Xiaochun Wan
Xiaochun Wan

CEO

Shenzhen BinDeBio Ltd.

Kangjian ZHANG
Kangjian ZHANG

Co-Founder, Director and GM

Yuansong Bio

Dr. Andrew LIN
Dr. Andrew LIN

Founder & CEO

Lingyi Biotherapeutics Co. Ltd

Mo MA
Mo MA

CEO

Shenzhen Eureka Biotechnology Co., Limited

Dr. Jinqiao WAN
Dr. Jinqiao WAN

Vice President of R&D Chemistry Center

HitGen Inc.

Chunying Li
Chunying Li

Technical Application Liaison, China

Mission Bio

Hongjiu DAI
Hongjiu DAI

CEO

Nanjing Kaedi Biotherapeutics

Prof. Evelyne Yehudit Bischof
Prof. Evelyne Yehudit Bischof

Professor Doctor

Shanghai University of Medicine and Health Sciences

Yongzhen LIU
Yongzhen LIU

Deputy Director of Center for Drug Safety Evaluation

Shanghai Institute of Materia Medica

Ryan CAWOOD
Ryan CAWOOD

Chief Scientific Officer

WuXi Advanced Therapies

 Lei ZHANG
Lei ZHANG

R&D VP

Neukio Biotherapeutics

Jimin GAO
Jimin GAO

Professor

Wenzhou Medical University

Ke ZHANG
Ke ZHANG

Chief Scientific Officer

SCG Cell

Yun YANG
Yun YANG

CTO

CirCode Bio

Yang WANG
Yang WANG

Director of Research and Development

Wuhan Binhui Biopharmaceutical

Xiaoxi XU
Xiaoxi XU

Director of In Vitro

Crown Bioscience

Mark FANG
Mark FANG

CQO

Shanghai Zhimi Medical Technology

Adam ZHAO
Adam ZHAO

President

AnlongBio

Yunxiang ZHU
Yunxiang ZHU

Vice President

CANbridge Pharma

Frank GAO
Frank GAO

Chief Strategy Officer

BRL Medicine

Tianhong XU
Tianhong XU

CEO

Base Therapeutics

Emily TAN
Emily TAN

Chief Operating Officer

Bennu Biotherapeutics

Fred MAO
Fred MAO

Partner & Managing Director

Frost & Sullivan

Yarong LIU
Yarong LIU

Founder

Grit Biotechnology

Lei SUN
Lei SUN

CTO

GeneMind

John LU
John LU

President & CEO

HebeCell

Yi ZHU
Yi ZHU

Chief Executive Officer

Hillgene

Grace Zhou
Grace Zhou

CEO

ImmVira Pharma

Xiaoqi QI
Xiaoqi QI

Associate Regional Marketing Manager

10x Genomics

Ways to Attend

Increase Your Visibility. Improve Your Reputation

Normal Ticket

  • 1 Pass

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs & Documentation


Exhibition Sponsor

  • 3 Passes

  • 6㎡or 9㎡ Booth for show

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Presentation Sponsor

( Slots Limited)

  • 5 Passes

  • 30 min Speech Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Gold Sponsor

(Exclusive)

  • 5 or More Passes

  • 30 min Speech Opportunity

  • 6or 9 Booth for show

  • Chairman Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Secure your ticket today

Early Bird tickets available now

Secure your spot at CGT Asia our special offer, and don’t go alone, enjoy the best group discount.

Register

Sponsors & Partners

Part of Media Partners

今日头条
搜狐
药智网
医谷网
CPHI制药在线
会会药咖
镁客网
化学加
人民医生网
研发客
肽度
大健康派
生物探索
药源网
基因线上
转化医学网
现代健康网
医药健闻
中国制药设备网
环球财经
商业观察网
医诺医学
美通社
动脉网
医疗器械创新网
化学网
中国仪器批发网
再生医学
盖德化工网
大健康网
阿仪网
张通社
测序宝
基因君
51健康网
中国健康咨询网
爱爱医
来宝网
露森科研
生物通
医学信息
中国生物器材网
分析测试百科网
全球医学会议网

Related Meetings